Cargando…
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
BACKGROUND: Calprotectin (S100A8/S100A9 protein) is known as a damage-associated molecular pattern (DAMP) protein and reflects mainly neutrophil activation. Serum calprotectin levels might be a good alternative to acute-phase protein as a biomarker in inflammatory rheumatic diseases. The aim of this...
Autores principales: | Jarlborg, Matthias, Courvoisier, Delphine S., Lamacchia, Céline, Martinez Prat, Laura, Mahler, Michael, Bentow, Chelsea, Finckh, Axel, Gabay, Cem, Nissen, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201559/ https://www.ncbi.nlm.nih.gov/pubmed/32375861 http://dx.doi.org/10.1186/s13075-020-02190-3 |
Ejemplares similares
-
Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance
por: Martinez-Prat, Laura, et al.
Publicado: (2018) -
Measuring ACPA in the general population or primary care: is it useful?
por: Finckh, Axel, et al.
Publicado: (2020) -
Association of circulating calprotectin with lipid profile in axial spondyloarthritis
por: Genre, Fernanda, et al.
Publicado: (2018) -
A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007) -
Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis
por: Brulhart, Laure, et al.
Publicado: (2019)